Perioperative beta-adrenergic antagonism: panacea or poison?
- PMID: 31248641
- PMCID: PMC6676158
- DOI: 10.1016/j.bja.2019.05.039
Perioperative beta-adrenergic antagonism: panacea or poison?
Conflict of interest statement
Neither author has a financial interest in the study of perioperative beta blockade. HY was the co-principal investigator of POISE. WSB has co-authored articles pertaining to the perioperative effects of beta blockade. These may be construed as academic conflicts of interest.
Comment on
-
Preoperative chronic beta-blocker prescription in elderly patients as a risk factor for postoperative mortality stratified by preoperative blood pressure: a cohort study.Br J Anaesth. 2019 Aug;123(2):118-125. doi: 10.1016/j.bja.2019.03.042. Epub 2019 May 14. Br J Anaesth. 2019. PMID: 31101323 Free PMC article.
References
-
- Viljoen J.F., Estafanous F.G., Kellner G.A. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg. 1972;64:826–830. - PubMed
-
- Ezekowitz J.A., O'Meara E., McDonald M.A. 2017 Comprehensive update of the Canadian Cardiovascular Society Guidelines for the management of heart failure. Can J Cardiol. 2017;33:1342–1433. - PubMed
-
- Jones C., Pollit V., Fitzmaurice D., Cowan C., Guideline Development Group The management of atrial fibrillation: summary of updated NICE guidance. BMJ. 2014;348:g3655. - PubMed
-
- Jones K., Saxon L., Cunningham W., Adams P., Guideline Development Group Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance. BMJ. 2013;347:f6544. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
